论文部分内容阅读
目的 利用依达拉奉注射液联合血栓通注射液治疗进展性脑梗死,观察其临床疗效.方法 将在48 h内发病的68例进展性脑梗死患者随机分为治疗组(34例)和对照组(34例).治疗组给予血栓通注射液联合给予依达拉奉静脉输注,连用14 d.对照组仅用同剂量、同疗程的血栓通注射液.密切注意两组病例的临床治疗效果及神经功能缺损改进情况,同时观察并记录患者的不良反应.结果 治疗2周后,治疗组总有效率为94.1％,优于对照组的70.6％(P＜0.05).对神经功能缺损进行评分,治疗两周后其改善情况明显对照组(P＜0.05).不良反应的发生率,两组患者之间无显著性差别(P＞0.05).结论 依达拉奉与血栓通注射液进行组合,规范治疗2周,在治疗急性脑梗死中有明显临床效果.“,”Objective To observe the clinical efficacy of edaravone injection combined with Xueshuantong injection in treatment of progressive cerebral infarction.Methods Sixty-eight patients with progressive cerebral infarction who were within 48 h were randomly divided into treatment group (n =34) and control group (n =34).The patients in the treatment group were treated with Xueshuantong injection combined with intravenous infusion of edaravone for 14 days.The control group only used the same dose,with the treatment of Xueshuantong injection.Pay attention to the two groups of cases of clinical treatment and neurological deficits improved,while observing and recording the patient's adverse reactions.Results After treatment for 2 weeks,the total effective rate was 94.1％ in the treatment group,which was better than that in the control group (70.6％,P ＜ 0.05).The neurological deficit was evaluated and the improvement was better in the control group (P ＜ 0.05) after two weeks of treatment.The incidence of adverse reactions was not signifi cantly different between the two groups (P ＞ 0.05).Conclusion Edaravone combined with Xueshuantong injection,standard treatment for 2 weeks,in the treatment of acute cerebral infarction in a significant clinical effect.